LAWRENCE DONEHOWER to Genetic Vectors
This is a "connection" page, showing publications LAWRENCE DONEHOWER has written about Genetic Vectors.
Connection Strength
0.303
-
Activities of wildtype and mutant p53 in suppression of homologous recombination as measured by a retroviral vector system. Mutat Res. 2003 Jan 28; 522(1-2):69-83.
Score: 0.159
-
Research and potential clinical applications of retroviral vectors. Prog Med Virol. 1987; 34:1-32.
Score: 0.052
-
Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype. Hum Gene Ther. 1993 Aug; 4(4):451-60.
Score: 0.021
-
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992 Mar 19; 356(6366):215-21.
Score: 0.019
-
55K isoform of CDK9 associates with Ku70 and is involved in DNA repair. Biochem Biophys Res Commun. 2010 Jun 25; 397(2):245-50.
Score: 0.016
-
Development of an HIV-based cDNA expression cloning system. Mol Ther. 2003 Jul; 8(1):167-73.
Score: 0.010
-
Generation and characterization of p53 mutant mice. Methods Mol Biol. 2003; 234:29-49.
Score: 0.010
-
p53 deficiency does not affect the accumulation of point mutations in a transgene target. Proc Natl Acad Sci U S A. 1995 Aug 29; 92(18):8517-21.
Score: 0.006
-
Inhibition of HIV-1 by a double transdominant fusion gene. Gene Ther. 1995 May; 2(3):181-6.
Score: 0.006
-
Gene-targeting and the p53 tumor-suppressor gene. Mutat Res. 1994 Jun 01; 307(2):557-72.
Score: 0.005